Peter M Neupert - Net Worth and Insider Trading

Peter M Neupert Net Worth

The estimated net worth of Peter M Neupert is at least $3 Million dollars as of 2024-11-05. Peter M Neupert is the Director of Labcorp Holdings Inc and owns about 10,254 shares of Labcorp Holdings Inc (LH) stock worth over $2 Million. Peter M Neupert is also the Director of Fortrea Holdings Inc and owns about 21,996 shares of Fortrea Holdings Inc (FTRE) stock worth over $376,132. Details can be seen in Peter M Neupert's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter M Neupert has not made any transactions after 2023-08-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Peter M Neupert

To

Peter M Neupert Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter M Neupert owns 4 companies in total, including Adaptive Biotechnologies Corp (ADPT) , Labcorp Holdings Inc (LH) , and NextGen Healthcare Inc (NXGN) among others .

Click here to see the complete history of Peter M Neupert’s form 4 insider trades.

Insider Ownership Summary of Peter M Neupert

Ticker Comapny Transaction Date Type of Owner
ADPT Adaptive Biotechnologies Corp 2023-03-06 director
LH Labcorp Holdings Inc 2022-02-16 director
NXGN NextGen Healthcare Inc 2013-08-15 director
LIMIT LIMIT 2023-08-23 director

Peter M Neupert Latest Holdings Summary

Peter M Neupert currently owns a total of 2 stocks. Among these stocks, Peter M Neupert owns 10,254 shares of Labcorp Holdings Inc (LH) as of February 16, 2022, with a value of $2 Million and a weighting of 86.2%. Peter M Neupert also owns 21,996 shares of Fortrea Holdings Inc (FTRE) as of August 23, 2023, with a value of $376,132 and a weighting of 13.8%.

Latest Holdings of Peter M Neupert

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LH Labcorp Holdings Inc 2022-02-16 10,254 229.11 2,349,294
FTRE Fortrea Holdings Inc 2023-08-23 21,996 17.10 376,132

Holding Weightings of Peter M Neupert


Peter M Neupert Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter M Neupert has made a total of 1 transactions in Labcorp Holdings Inc (LH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Labcorp Holdings Inc is the acquisition of 3,500 shares on February 16, 2022, which cost Peter M Neupert around $922,810.

According to the SEC Form 4 filings, Peter M Neupert has made a total of 1 transactions in Fortrea Holdings Inc (FTRE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fortrea Holdings Inc is the acquisition of 11,000 shares on August 23, 2023, which cost Peter M Neupert around $278,300.

Insider Trading History of Peter M Neupert

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter M Neupert Trading Performance

GuruFocus tracks the stock performance after each of Peter M Neupert's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter M Neupert is 9.72%. GuruFocus also compares Peter M Neupert's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter M Neupert within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peter M Neupert's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peter M Neupert

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.59 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 8.2 LIMIT LIMIT LIMIT LIMIT LIMIT

Peter M Neupert Ownership Network

Ownership Network List of Peter M Neupert

No Data

Ownership Network Relation of Peter M Neupert

Insider Network Chart

Peter M Neupert Owned Company Details

What does Adaptive Biotechnologies Corp do?

Who are the key executives at Adaptive Biotechnologies Corp?

Peter M Neupert is the director of Adaptive Biotechnologies Corp. Other key executives at Adaptive Biotechnologies Corp include SVP and General Counsel Stacy L Taylor , Chief Financial Officer Tycho Peterson , and Principal Accounting Officer Kyle Piskel .

Adaptive Biotechnologies Corp (ADPT) Insider Trades Summary

Over the past 18 months, Peter M Neupert made no insider transaction in Adaptive Biotechnologies Corp (ADPT). Other recent insider transactions involving Adaptive Biotechnologies Corp (ADPT) include a net sale of 258,417 shares made by Tycho Peterson , a net sale of 40,303 shares made by Stacy L Taylor , and a net sale of 7,986 shares made by Kyle Piskel .

In summary, during the past 3 months, insiders sold 26,922 shares of Adaptive Biotechnologies Corp (ADPT) in total and bought 0 shares, with a net sale of 26,922 shares. During the past 18 months, 467,732 shares of Adaptive Biotechnologies Corp (ADPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 467,732 shares.

Adaptive Biotechnologies Corp (ADPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adaptive Biotechnologies Corp Insider Transactions

No Available Data

Peter M Neupert Mailing Address

Above is the net worth, insider trading, and ownership report for Peter M Neupert. You might contact Peter M Neupert via mailing address: 13920 Se Eastgate Way, Ste 300, Bellevue Wa 98005.